Attention and working memory deficits in a perinatal nicotine exposure mouse model
- PMID: 29795664
- PMCID: PMC5967717
- DOI: 10.1371/journal.pone.0198064
Attention and working memory deficits in a perinatal nicotine exposure mouse model
Abstract
Background: Cigarette smoking by pregnant women is associated with a significant increase in the risk for cognitive disorders in their children. Preclinical models confirm this risk by showing that exposure of the developing brain to nicotine produces adverse behavioral outcomes. Here we describe behavioral phenotypes resulting from perinatal nicotine exposure in a mouse model, and discuss our findings in the context of findings from previously published studies using preclinical models of developmental nicotine exposure.
Methodology/principal findings: Female C57Bl/6 mice received drinking water containing nicotine (100μg/ml) + saccharin (2%) starting 3 weeks prior to breeding and continuing throughout pregnancy, and until 3 weeks postpartum. Over the same period, female mice in two control groups received drinking water containing saccharin (2%) or plain drinking water. Offspring from each group were weaned at 3-weeks of age and subjected to behavioral analyses at 3 months of age. We examined spontaneous locomotor activity, anxiety-like behavior, spatial working memory, object based attention, recognition memory and impulsive-like behavior. We found significant deficits in attention and working memory only in male mice, and no significant changes in the other behavioral phenotypes in male or female mice. Exposure to saccharin alone did not produce significant changes in either sex.
Conclusion/significance: The perinatal nicotine exposure produced significant deficits in attention and working memory in a sex-dependent manner in that the male but not female offspring displayed these behaviors. These behavioral phenotypes are associated with attention deficit hyperactivity disorder (ADHD) and have been reported in other studies that used pre- or perinatal nicotine exposure. Therefore, we suggest that preclinical models of developmental nicotine exposure could be useful tools for modeling ADHD and related disorders.
Conflict of interest statement
Lin Zhang: Nothing to declare. Pradeep Bhide: Dr. Bhide is a co-founder and consultant to Avekshan LLC, Tallahassee, FL, a pharmaceutical enterprise engaged in the development of novel therapies for attention deficit hyperactivity disorder (ADHD). Dr. Bhide is an inventor in following patents or patent applications relevant to ADHD therapy: US Patent, “Class of non-stimulant treatment and ADHD and related disorders” (#US9623023 B2), and US patent application, “Methods and compositions to prevent addiction (#US20130289061 A1). Thomas Spencer: Dr. Spencer received research support or was a consultant from the following sources: Alcobra, Avekshan, Ironshore, Lundbeck, Shire Laboratories Inc, Sunovion, the FDA and the Department of Defense. Consultant fees are paid to the Clinical Trials Network at the Massachusetts General Hospital (MGH) and not directly to Dr. Spencer. Dr. Spencer has been on an advisory board for the following pharmaceutical companies: Alcobra. Dr. Spencer received research support from Royalties and Licensing fees on copyrighted ADHD scales through MGH Corporate Sponsored Research and Licensing. Through MGH corporate licensing, Dr. Spencer is an inventor on a US Patent, “Class of non-stimulant treatment and ADHD and related disorders” (#US9623023 B2), and US patent application, “Methods and compositions to prevent addiction (#US20130289061 A1). Joseph Biederman: Dr. Biederman is currently receiving research support from the following sources: AACAP, The Department of Defense, Food & Drug Administration, Headspace, Lundbeck, Neurocentria Inc., NIDA, PamLab, Pfizer, Shire Pharmaceuticals Inc., Sunovion, and NIH. Dr. Biederman has a financial interest in Avekshan LLC, a company that develops treatments for attention deficit hyperactivity disorder (ADHD). His interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. Dr. Biederman’s program has received departmental royalties from a copyrighted rating scale used for ADHD diagnoses, paid by Ingenix, Prophase, Shire, Bracket Global, Sunovion, and Theravance; these royalties were paid to the Department of Psychiatry at MGH. In 2017, Dr. Biederman is a consultant for Aevi Genomics, Akili, Guidepoint, Ironshore, Medgenics, and Piper Jaffray. He is on the scientific advisory board for Alcobra and Shire. He received honoraria from the MGH Psychiatry Academy for tuition-funded CME courses. Through MGH corporate licensing, he is an inventor on US Patent, “Class of non-stimulant treatment and ADHD and related disorders” (#US9623023 B2), and US patent application, “Methods and compositions to prevent addiction (#US20130289061 A1). In 2016, Dr. Biederman received honoraria from the MGH Psychiatry Academy for tuition-funded CME courses, and from Alcobra and APSARD. He was on the scientific advisory board for Arbor Pharmaceuticals. He was a consultant for Akili and Medgenics. He received research support from Merck and SPRITES. We confirm that our competing interests or commercial support do not alter our adherence to all PLOS ONE policies on sharing data and materials.
Figures
Similar articles
-
A prenatal nicotine exposure mouse model of methylphenidate responsive ADHD-associated cognitive phenotypes.Int J Dev Neurosci. 2017 May;58:26-34. doi: 10.1016/j.ijdevneu.2017.01.014. Epub 2017 Feb 4. Int J Dev Neurosci. 2017. PMID: 28179105
-
Effects of Developmental Nicotine Exposure on Frontal Cortical GABA-to-Non-GABA Neuron Ratio and Novelty-Seeking Behavior.Cereb Cortex. 2020 Mar 14;30(3):1830-1842. doi: 10.1093/cercor/bhz207. Cereb Cortex. 2020. PMID: 31599922 Free PMC article.
-
Prenatal nicotine exposure in mice induces sex-dependent anxiety-like behavior, cognitive deficits, hyperactivity, and changes in the expression of glutamate receptor associated-genes in the prefrontal cortex.Pharmacol Biochem Behav. 2020 Aug;195:172951. doi: 10.1016/j.pbb.2020.172951. Epub 2020 May 19. Pharmacol Biochem Behav. 2020. PMID: 32439454
-
Behavioral and neural consequences of prenatal exposure to nicotine.J Am Acad Child Adolesc Psychiatry. 2001 Jun;40(6):630-41. doi: 10.1097/00004583-200106000-00007. J Am Acad Child Adolesc Psychiatry. 2001. PMID: 11392340 Review.
-
Long-term consequences of maternal smoking and developmental chronic nicotine exposure.Front Biosci. 2008 Jan 1;13:636-49. doi: 10.2741/2708. Front Biosci. 2008. PMID: 17981576 Review.
Cited by
-
Deep-Learning-Based Analysis Reveals a Social Behavior Deficit in Mice Exposed Prenatally to Nicotine.Cells. 2024 Feb 1;13(3):275. doi: 10.3390/cells13030275. Cells. 2024. PMID: 38334667 Free PMC article.
-
Investigating Behavioral and Neuronal Changes in Adolescent Mice Following Prenatal Exposure to Electronic Cigarette (E-Cigarette) Vapor Containing Nicotine.Brain Sci. 2023 Oct 6;13(10):1417. doi: 10.3390/brainsci13101417. Brain Sci. 2023. PMID: 37891786 Free PMC article.
-
Learning and memory deficits produced by aspartame are heritable via the paternal lineage.Sci Rep. 2023 Aug 31;13(1):14326. doi: 10.1038/s41598-023-41213-2. Sci Rep. 2023. PMID: 37652922 Free PMC article.
-
Beneficial role of rosemary extract on oxidative stress-mediated neuronal apoptosis in rotenone-induced attention deficit hyperactivity disease in juvenile rat model.Acta Biomed. 2023 Jun 14;94(3):e2023104. doi: 10.23750/abm.v94i3.14260. Acta Biomed. 2023. PMID: 37326266 Free PMC article.
-
Necessity of an Integrative Animal Model for a Comprehensive Study of Attention-Deficit/Hyperactivity Disorder.Biomedicines. 2023 Apr 24;11(5):1260. doi: 10.3390/biomedicines11051260. Biomedicines. 2023. PMID: 37238931 Free PMC article. Review.
References
-
- Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM. Current Cigarette Smoking Among Adults—United States, 2005–2015. Atlanta, GA: Centers for Disease Control, 2016 November 2016. Report No.: Contract No.: 44. - PubMed
-
- Report USSGs. E-Cigarette Use Among Youth and Young Adults: A Report of the Surgeon General. Washington, D.C.: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2016 2016. Report No.
-
- Alkam T, Kim HC, Hiramatsu M, Mamiya T, Aoyama Y, Nitta A, et al. Evaluation of emotional behaviors in young offspring of C57BL/6J mice after gestational and/or perinatal exposure to nicotine in six different time-windows. Behav Brain Res. 2013;239:80–9. doi: 10.1016/j.bbr.2012.10.058 . - DOI - PubMed
-
- Alkam T, Kim HC, Mamiya T, Yamada K, Hiramatsu M, Nabeshima T. Evaluation of cognitive behaviors in young offspring of C57BL/6J mice after gestational nicotine exposure during different time-windows. Psychopharmacology (Berl). 2013;230(3):451–63. doi: 10.1007/s00213-013-3175-9 . - DOI - PubMed
-
- Hall BJ, Cauley M, Burke DA, Kiany A, Slotkin TA, Levin ED. Cognitive and Behavioral Impairments Evoked by Low-Level Exposure to Tobacco Smoke Components: Comparison with Nicotine Alone. Toxicol Sci. 2016;151(2):236–44. doi: 10.1093/toxsci/kfw042 ; PubMed Central PMCID: PMC4880133. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
